News OECD calls for 'rebalancing of power' in drug price negotiat... Health systems should fund more treatments for chronic diseases, says EFPIA
Views & Analysis Digital health round-up – health innovations shine at CES 20... A round-up of this week’s top digital healthcare news. Marco Ricci reports.
News New Lilly CEO wields axe after Alzheimer's failure David Ricks revamps organisation after trial disappointment.
News Lilly/Boehringer diabetes combos get cardio data boost Lilly/Boehringer gain further advantage in US diabetes market.
News Verily and Nikon to collaborate on machine learning in diabe... Alliance will seek to improve screening for common diabetic vision conditions.
News Court sides with EU on decision to revoke Ocaliva's license Advanz Pharma's bid to keep its Ocaliva treatment for rare liver disease primary biliary cholangitis (PBC) on the EU market has ended in failure
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
